Skip to main content
FinSpry Logo
FinSpry
NRSN logo
NRSN
(NASDAQ)
NeuroSense Therapeutics Ltd.
$0.83-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

NeuroSense Therapeutics (NRSN) Stock Price & Financial Analysis

NeuroSense Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.76 - $0.84
52-Week High$2.60
52-Week Low$0.63
Open$0.77
Volume99.04K
Average Volume (3M)99.04K
Market Cap21.08M
Shares Outstanding25.40M
EV/EBITDA-2.27
50-Day MA$0.87
200-Day MA$1.19
52-Week Change-16.37%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About NeuroSense Therapeutics

What is the current stock price for NRSN?

As of the latest trading session, NRSN stock trades at $0.83. The 52-week range is $0.63–$2.60, with a day range of $0.76–$0.84.

What is the P/E ratio for NRSN?

The P/E ratio (Price-to-Earnings) for NRSN is shown in the Key Statistics section. This valuation metric helps compare NeuroSense Therapeutics Ltd. to industry peers.

Does NRSN pay dividends?

NeuroSense Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for NRSN?

Based on 2 analysts, the consensus for NRSN is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of NRSN?

NeuroSense Therapeutics's market capitalization is $21.1M, classifying it as a micro-cap company. NeuroSense Therapeutics operates in the Healthcare sector within the Biotechnology industry.